Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 45551-45600 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06109142
Clearance of Vasoactive Metabolites With Blood Purification
N/ARecruiting
30 participants
Started: Jul 11, 2024 · Completed: Jun 11, 2026
1 condition1 sponsor3 locations
NCT06091202
Tele-Collaborative Outreach to Rural Patients With Chronic Pain
PHASE3Recruiting
608 participants
Started: Jul 11, 2024 · Completed: Jun 1, 2027
1 condition6 sponsors4 locations
NCT06505837
JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer(NSCLC)
PHASE3Active, not recruiting
395 participants
Started: Jul 11, 2024 · Completed: Dec 30, 2026
1 condition2 sponsors1 location
NCT07145138
UIC Multi-Ethnic DCM Registry
N/ARecruiting
1,500 participants
Started: Jul 11, 2024 · Completed: Dec 31, 2038
2 conditions1 sponsor1 location
NCT06374875
Fibrosis Lessens After Metabolic Surgery
PHASE4Recruiting
120 participants
Started: Jul 11, 2024 · Completed: Dec 31, 2029
5 conditions2 sponsors22 locations
NCT06515795
Evaluation of Two Isometric Exercises in the Reduction of the Blood Pressure in People With Resistant Hypertension
NARecruiting
15 participants
Started: Jul 11, 2024 · Completed: Sep 30, 2024
1 condition2 sponsors1 location
NCT05662462
Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching
NARecruiting
124 participants
Started: Jul 11, 2024 · Completed: Mar 31, 2029
4 conditions3 sponsors1 location
NCT06069648
Effects of Decision Aids on the Participation of South Asian Women in Cervical Cancer Screening
NANot yet recruiting
270 participants
Started: Jul 11, 2024 · Completed: Mar 10, 2026
1 condition1 sponsor0 locations
NCT06500819
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors
PHASE1Recruiting
41 participants
Started: Jul 11, 2024 · Completed: Jul 31, 2029
3 conditions1 sponsor1 location
NCT06601309
Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC
PHASE2Recruiting
90 participants
Started: Jul 11, 2024 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT07019584
"Wai Ji Match Fun Card Games for People With Intellectual Disabilities"
NAActive, not recruiting
60 participants
Started: Jul 11, 2024 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT06319846
Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4)
PHASE3Recruiting
4,674 participants
Started: Jul 11, 2024 · Completed: Dec 31, 2026
3 conditions1 sponsor5 locations
NCT06513234
Combination of Orelabrutinib and Obinutuzumab in Untreated Marginal Zone Lymphomas
PHASE2Recruiting
45 participants
Started: Jul 11, 2024 · Completed: Jun 21, 2029
1 condition1 sponsor1 location
NCT06046443
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity
PHASE2Active, not recruiting
28 participants
Started: Jul 11, 2024 · Completed: Jan 31, 2026
1 condition1 sponsor10 locations
NCT06507579
Hydra Registry - UK
N/ARecruiting
250 participants
Started: Jul 11, 2024 · Completed: Aug 1, 2026
1 condition2 sponsors4 locations
NCT06558981
Adjuvant Radiotherapy in High Risk Locally Advanced DTC
PHASE3Recruiting
124 participants
Started: Jul 11, 2024 · Completed: Jun 30, 2031
1 condition1 sponsor1 location
NCT06562114
A Phase 1 Safety and Tolerability Study of TML-6 in Healthy and Elderly Volunteers for Alzheimer's Disease Treatment
PHASE1Recruiting
72 participants
Started: Jul 11, 2024 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT06441591
Clinical Outcome of Vinpocetine in Diabetic Nephropathy
PHASE2/PHASE3Recruiting
64 participants
Started: Jul 10, 2024 · Completed: Jun 1, 2025
2 conditions1 sponsor2 locations
NCT06324812
Evaluation of 611 in Chinese Children and Adolescents With Moderate to Severe Atopic Dermatitis
PHASE1/PHASE2Recruiting
124 participants
Started: Jul 10, 2024 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT06515613
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
PHASE1Recruiting
80 participants
Started: Jul 10, 2024 · Completed: Mar 31, 2028
3 conditions1 sponsor8 locations
NCT06420076
Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells
PHASE1/PHASE2Recruiting
60 participants
Started: Jul 10, 2024 · Completed: Dec 28, 2026
6 conditions1 sponsor1 location
NCT06681688
Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC
PHASE1/PHASE2Recruiting
94 participants
Started: Jul 10, 2024 · Completed: Aug 31, 2025
1 condition2 sponsors2 locations
NCT06473948
To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy Subjects
PHASE1Not yet recruiting
27 participants
Started: Jul 10, 2024 · Completed: Feb 27, 2025
1 condition1 sponsor0 locations
NCT06709755
A Hybrid Effectiveness-implementation Trial to Reduce Diabetes Distress in Teenagers
NARecruiting
360 participants
Started: Jul 10, 2024 · Completed: Mar 15, 2029
1 condition3 sponsors1 location
NCT06213636
Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).
PHASE1/PHASE2Recruiting
75 participants
Started: Jul 10, 2024 · Completed: Dec 10, 2028
7 conditions1 sponsor1 location
NCT06681883
Implementation of the Model of Modifiable Factors Specific to Problematic Internet Use in Adolescents
NAEnrolling by invitation
10 participants
Started: Jul 10, 2024 · Completed: Jan 10, 2025
2 conditions1 sponsor1 location
NCT06208657
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
PHASE1/PHASE2Recruiting
82 participants
Started: Jul 10, 2024 · Completed: Dec 31, 2035
5 conditions6 sponsors11 locations
NCT06791148
Low-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in Patients With Advanced G/GEJ Cancer
PHASE2Recruiting
45 participants
Started: Jul 10, 2024 · Completed: Dec 10, 2027
1 condition1 sponsor1 location
NCT06350110
Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)
PHASE1/PHASE2Recruiting
75 participants
Started: Jul 10, 2024 · Completed: Dec 28, 2025
9 conditions1 sponsor1 location
NCT06497946
Effects of SlimTrack® Platform on Diet Adherence, Anthropometry and Arterial Stiffness in Postmenopausal Women
NARecruiting
64 participants
Started: Jul 10, 2024 · Completed: Nov 30, 2025
3 conditions1 sponsor1 location
NCT06363721
A Pilot Study of a Commercially-available Oil Rinse Product (PerioPull™) on Markers of Dental Health
NARecruiting
18 participants
Started: Jul 10, 2024 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT06498050
Brolucizumab Efficacy and Safety Single-Arm Descriptive Trial in Patients With Persistent Diabetic Macular Edema
PHASE4Active, not recruiting
52 participants
Started: Jul 10, 2024 · Completed: Jul 10, 2025
1 condition2 sponsors1 location
NCT06420063
Sequential CAR-T Cells Targeting CD33/CD123 in Patients With Acute Myelocytic Leukemia AML
PHASE1/PHASE2Recruiting
85 participants
Started: Jul 10, 2024 · Completed: Dec 28, 2026
4 conditions1 sponsor1 location
NCT06512311
Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening
NARecruiting
240 participants
Started: Jul 10, 2024 · Completed: Dec 31, 2031
1 condition1 sponsor1 location
NCT06187103
Evaluation of Improved Onboard Patient Imaging
NARecruiting
40 participants
Started: Jul 10, 2024 · Completed: Oct 31, 2025
5 conditions1 sponsor1 location
NCT06274294
Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous as Induction Therapy in Patients With Active CD or UC
PHASE3Recruiting
130 participants
Started: Jul 10, 2024 · Completed: Jan 31, 2025
1 condition3 sponsors1 location
NCT06247111
Monitoring Blood Pressure at Home
NAActive, not recruiting
24 participants
Started: Jul 10, 2024 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT06130514
The Comparison of Sympathetic Blockade of Stellate Ganglion Block and Thoracic Sympathetic Ganglion Block
NANot yet recruiting
118 participants
Started: Jul 10, 2024 · Completed: Jan 10, 2026
5 conditions1 sponsor0 locations
NCT06557642
Nitrous Oxide and EMOtional Cognition
NARecruiting
88 participants
Started: Jul 10, 2024 · Completed: Oct 1, 2025
1 condition1 sponsor1 location
NCT06547086
Rapid Eye Movement Restoration and Enhancement for Sleep-deprived Trauma-adaptation
NARecruiting
80 participants
Started: Jul 10, 2024 · Completed: Feb 28, 2026
1 condition2 sponsors1 location
NCT06330025
Exploring Food Rejection Dispositions as Potential Risk Factors for Undernutrition in Hospitalized Children Aged 2 to 8
N/ARecruiting
102 participants
Started: Jul 10, 2024 · Completed: Jan 10, 2026
1 condition1 sponsor1 location
NCT06753383
Effectiveness of Virtual Reality- Based Rehabilitation Program in Individuals With Adolescent Idiopathic Scoliosis After Posterior Fusion Surgery
NAEnrolling by invitation
28 participants
Started: Jul 10, 2024 · Completed: Jul 21, 2025
1 condition2 sponsors1 location
NCT06046742
A Study of Intravenous M1-c6v1 for Locally Advanced or Metastatic Solid Tumors
PHASE1Recruiting
12 participants
Started: Jul 10, 2024 · Completed: Dec 20, 2026
1 condition1 sponsor3 locations
NCT06490419
Effect of Ultrasound Cavitation Versus Electrolipolysis on Obese Infertile Women With Polycystic Ovarian Syndrome
NANot yet recruiting
30 participants
Started: Jul 10, 2024 · Completed: Dec 10, 2024
1 condition1 sponsor0 locations
NCT06377527
Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)
N/ARecruiting
2,000 participants
Started: Jul 10, 2024 · Completed: Dec 28, 2037
1 condition1 sponsor1 location
NCT06496308
Bendamustine and Rituximab With or Without Orelabrutinib in MCL Treatment
PHASE3Recruiting
78 participants
Started: Jul 10, 2024 · Completed: Jul 10, 2027
1 condition9 sponsors1 location
NCT06507761
Thermotherapy in Acute Nonspecific Neck Pain
NARecruiting
60 participants
Started: Jul 10, 2024 · Completed: Jul 10, 2025
2 conditions1 sponsor2 locations
NCT06683690
TGF β 1 Expression Related Gene Polymorphism
N/ARecruiting
60 participants
Started: Jul 10, 2024 · Completed: Jul 10, 2025
1 condition1 sponsor1 location
NCT05901194
Lenvatinib Treatment in Waiting List of Liver Transplantation After TACE Failure in Patients With Hepatocellular Carcinoma
PHASE1/PHASE2Active, not recruiting
25 participants
Started: Jul 10, 2024 · Completed: Apr 30, 2027
1 condition2 sponsors6 locations
NCT06851676
Functional and Metabolic Effects of Fonte Fausta® Water on Bone and Muscle Health in Osteoporotic Patients
NARecruiting
100 participants
Started: Jul 10, 2024 · Completed: Sep 10, 2025
2 conditions2 sponsors1 location